Is clinical heterogeneity the foremost prominent threat to the validity of meta-analyses?

Systematic review methodology with meta-analyses have long been regarded as one of the highest forms of research methodology and a cornerstone in many clinical guidelines. A common criticism of this methodology is the handling of the clinical and/or statistical heterogeneity which arises when pooling heterogenous data from different trials, settings and interventions.